National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 5) (PB 61 of 2015) (Cth)

PB 61 of 2015

National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 5)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary , Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated           1       July 2015

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 5).

(2)   This Determination may also be cited as PB 61 of 2015.

1. Commencement

This Determination commences on 1 July 2015.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Cortisone

Insert

Crizotinib

[2]     Schedule 1, after item dealing with Permethrin

Insert

Pertuzumab

[3]     Schedule 1, after item dealing with Trastuzumab

Insert

Trastuzumab emtansine